Overview

The Effect of Remimazolam on Opioid Induced Hyperalgesia

Status:
Recruiting
Trial end date:
2023-06-30
Target enrollment:
Participant gender:
Summary
The goal of this prospective, randomized, controlled study is to investigate the effect of remimazolam on opioid-induced hyperalgesia (OIH) in patients undergoing single port-laparoscopically assisted urologic surgery. The main question[s] it aims to answer are: - [The mechanical hyperalgesia threshold] - [Area of hyperalgesia around the surgical incision 24 h after surgery (cm^2)] In three groups: Group RHR (Remimazolam- High-dose Remifentanil), Group DHR (Desflurane-low-dose Remifentanil) or Group DLR (Control).
Phase:
N/A
Details
Lead Sponsor:
Wonkwang University Hospital
Treatments:
Desflurane
Remifentanil